ESG risk score 14.59
Environmental score 1.44
Social score 9.8
Governance score 3.35
ESG risk category Low
Negligible Low Med High Severe
0-10 10-20 20-30 30-40 40+
Bristol-Myers Squibb Co.
000.00
0.00 / 0.00%
00:00:00
52 week range
0000.00 000.00
Symbol BMY:xnys
Currency USD
New York Stock Exchange
Open Closed
15 minutes delayed
Data provided by 
This information is not currently available for this instrument. Refresh the page or try again later.
Want to start investing?
Trade stocks with a broker trusted by over 1.5 million clients. Investing involves risk. You may lose some or all of your investment.
Chart
This information is not currently available for this instrument. Refresh the page or try again later.
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer.
Quotes
- Bid
- Ask
- Open
- Previous close
- Volume
- Relative volume
- High
- Low
This information is not currently available for this instrument. Refresh the page or try again later.
Returns
Year to date (YTD) 9.99%
1 year 7.29%
3 years -16.13%
Data provided by 
Key stats
Price/earnings (LTM) 17.15
Dividend yield (LTM) 4.2%
EPS (LTM) 3.46
Volatility (30 days) 25.79%
Data provided by
ESG risk
ESG risk is a measure of how well a company manages material ESG risks. Sustainalytics’ ESG risk category is designed to help investors identify and understand financially material ESG risks at the company level and how they might affect the long-term performance for equity investments. The scale is from 0-100. The lower the risk, the better (0 is equivalent to no risk and 100 the most severe).
Download ESG risk methodology (PDF)Data provided by 
/ 
/ Financials
Q1 Q2 Q3 Q4
Income statement
Revenue XXXXXXX XXXXXXX XXXXXXX XXXXXXX
EBITDA XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Net income XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Balance sheet
Total assets XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Total debt XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Ratios
Price/sales XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Earnings per share XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Dividend per share XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Return on equity XXXXXXX XXXXXXX XXXXXXX XXXXXXX
About Bristol-Myers Squibb Co.
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
Sector Healthcare
Industry -
Market cap 117bn
Data provided by /
/ Others were interested in
See all stocksFrequently asked questions
To buy Bristol-Myers Squibb Co. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Bristol-Myers Squibb Co. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Bristol-Myers Squibb Co. is BMY:xnys. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Bristol-Myers Squibb Co. has its primary listing on New York Stock Exchange. You can trade Bristol-Myers Squibb Co. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Bristol-Myers Squibb Co. is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Bristol-Myers Squibb Co. as part of a broader investment portfolio.